It is vital - given  an unemployment rate hovering around 9 percent and numerous costly new  regulations coming from this administration - that we make sure any TSCA reforms  help to not only protect human health, but jobs and the economy. My interest in  TSCA modernization - which I have said before - is in large part due to TSCA's  broad reach over chemical manufacturing and its potential, and real, impacts on  the economy. TSCA regulates the manufacturing, distribution, use, and disposal  of chemicals-authority that covers thousands of transactions and decisions by  thousands of people every day. I have consistently said that TSCA modernization  must be accomplished with a broad base of support, including industry up and  down the value chain. It also must take into account the small and medium size  businesses that could be affected the most if the law is updated improperly. . .  My principles for reform remain the same: any modernization of TSCA should be  based on the best available science; use a risk-based standard for chemical  reviews; include cost-benefit considerations; protect proprietary information;  and must prioritize reviews for existing chemicals."
         Senator  Lautenberg reviewed the history of the Committee consideration over the past two  years and five hearings and said, "Our hearings revealed that the status quo does not work for  the chemical industry, either. In a hearing last February, executives from Dow  and DuPont, two major chemical companies, testified in support of reform, in  part because of the difficulties their companies face operating under different  rules in different states. We heard similar messages earlier this year from the  chemical maker, BASF, and S.C. Johnson, the global consumer product company. And  we heard from colleagues on both sides of the aisle who agreed TSCA must be  revised to work better for businesses and the health of our citizens. . .  "Earlier this year, Senator Inhofe and I met about trying to make this bill  bipartisan, and he suggested a process for getting more ideas from industry and  others on the table. Throughout the summer, our staffs held 10 meetings with  representatives from industry, labor, and environmental groups on different  sections of the Safe Chemicals Act. . ."
  
     He   concluded saying, "The bottom  line is this: this legislation establishes a strong, but practical system for  guaranteeing the safety of chemicals, many of which end up in our bodies and the  bodies of our children. And we remain open to other ways of achieving our shared  goal of a system that improves safety and encourages continued innovation and  growth in the chemical industry. But we must act on this issue soon. I plan to  call for a vote in this committee in the near future. I hope we will be able to  address any concerns raised today so we can approve a bipartisan bill that  encourages the use of chemicals that help, and protects our children from the  chemicals that harm." 
    American Chemistry Council (ACC) testified that, "Unfortunately. . . today we are discussing a bill that remains very  similar to the bill introduced in 2010, which we consider unworkable."  In his testimony Dooley outlined several fundamental  flaws with the bill, including an unachievable safety standard, data  requirements that would undermine the success of the current program to evaluate  new chemicals, the creation of an overly burdensome and unnecessary minimum date  set for all chemicals, and the lack of an effective prioritization  process. He said, "We also believe that S.847 would compromise the protection  of confidential business information, inappropriately expand the U.S.  Environmental Protection Agency's (EPA) authority into the jurisdiction of other  federal agencies such as the U.S. Food and Drug Administration (FDA), further  complicate issues surrounding national uniformity of standards, and fail to  adequately consider animal welfare."             Environmental Defense  Fund (EDF) on behalf of the Safer Chemicals, Healthy Families, a coalition of  over 300 organizations that speak for more than 11 million Americans. The  coalition includes groups representing health professionals and health-affected  populations and communities, environmental justice organizations, leading  businesses, and state and national environmental groups -- all of whom came  together to urge Congress to fundamentally reform the Toxic Substances Control  Act of 1976. After outlining a series of problems with TSCA, EDF said,  "All of these problems would be largely or entirely  ameliorated by adoption of legislation introduced this year, S.847, the Safe  Chemicals Act of 2011. It provides the framework for a comprehensive, systematic  solution to a set of problems that until now have only been addressed -- if at  all -- through reactive, piecemeal actions. 
    EDF said, "We have ongoing  dialogues with the American Chemistry Council (ACC) and the Consumer Specialty  Products Association (CSPA) and more than a dozen of their member companies;  these have involved many days of substantive meetings on key issues in TSCA  reform over the past six months. . . While  confidentiality agreements preclude me from discussing details, let me say that  in our dialogue with CSPA we are on the cusp of agreement on recommendations to  consider in the legislation that would address two key needs in TSCA reform:  balancing public access to chemical information with the need to protect  legitimate confidential business information; and designing a system to provide  EPA with more robust information on how chemicals are used for purposes of both  prioritizing and assessing the safety of chemicals. I have  come away from my deep involvement in these dialogues with the belief that there  is not a single major issue in TSCA reform for which, working together, we  cannot find a solution. .  ."   
1 comment:
The potential for chemical reform is quite exciting, but it should be done in a way that doesn’t sacrifice millions of animals (for toxicity testing) in the name of better protection for human health and the environment. The revised bill should mandate and create market incentives to use nonanimal methods. We need to ensure that chemical testing is in line with the 21st century and relies on modern, human cell and computer-based methods that provide accurate data on how a chemical acts and what the impact on human health may be.
Post a Comment